DD Gladman

676 total citations
19 papers, 341 citations indexed

About

DD Gladman is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, DD Gladman has authored 19 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 13 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in DD Gladman's work include Systemic Lupus Erythematosus Research (10 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Atherosclerosis and Cardiovascular Diseases (7 papers). DD Gladman is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Atherosclerosis and Cardiovascular Diseases (7 papers). DD Gladman collaborates with scholars based in Canada, United States and Australia. DD Gladman's co-authors include Murray B. Urowitz, Zahi Touma, Dominique Ibañez, Mandana Nikpour, Mahmoud Abu‐Shakra, Lihi Eder, Susan Ritchie, Jiandong Su, Jacqueline Hochman and Konstantinos Tselios and has published in prestigious journals such as Annals of the Rheumatic Diseases, Value in Health and Lupus.

In The Last Decade

DD Gladman

17 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DD Gladman Canada 12 290 192 57 49 42 19 341
T Y Lian Singapore 7 396 1.4× 223 1.2× 64 1.1× 83 1.7× 47 1.1× 13 459
Weng Giap Law Singapore 11 331 1.1× 180 0.9× 46 0.8× 110 2.2× 47 1.1× 16 429
Michelle Petri United States 2 301 1.0× 189 1.0× 36 0.6× 43 0.9× 53 1.3× 3 328
Ziqian Wang China 12 315 1.1× 157 0.8× 61 1.1× 82 1.7× 15 0.4× 31 402
K. Veres Hungary 7 214 0.7× 170 0.9× 26 0.5× 28 0.6× 39 0.9× 11 333
Hector Arbillaga Canada 9 312 1.1× 165 0.9× 61 1.1× 65 1.3× 11 0.3× 11 344
Ka Lung Yu China 7 319 1.1× 200 1.0× 36 0.6× 53 1.1× 10 0.2× 9 351
Tina Mahajan United States 9 288 1.0× 161 0.8× 42 0.7× 51 1.0× 14 0.3× 11 430
Shirley King Yee Ying China 8 221 0.8× 136 0.7× 41 0.7× 23 0.5× 16 0.4× 14 263
С. И. Глухова Russia 8 205 0.7× 106 0.6× 18 0.3× 38 0.8× 22 0.5× 149 316

Countries citing papers authored by DD Gladman

Since Specialization
Citations

This map shows the geographic impact of DD Gladman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DD Gladman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DD Gladman more than expected).

Fields of papers citing papers by DD Gladman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DD Gladman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DD Gladman. The network helps show where DD Gladman may publish in the future.

Co-authorship network of co-authors of DD Gladman

This figure shows the co-authorship network connecting the top 25 collaborators of DD Gladman. A scholar is included among the top collaborators of DD Gladman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DD Gladman. DD Gladman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Duarte‐García, Alí, Lihi Eder, Alisa J. Stephens‐Shields, et al.. (2018). Construct Validity of the Swollen and Tender Joint Counts for the Measurement of MSK Disease Activity in Psoriatic Arthritis. White Rose Research Online (University of Leeds, The University of Sheffield, University of York).
2.
3.
4.
Tselios, Konstantinos, et al.. (2017). Shrinking lung syndrome in systemic lupus erythematosus: a single-centre experience. Lupus. 27(3). 365–371. 24 indexed citations
5.
Coates, Laura C., DD Gladman, Peter Nash, et al.. (2017). SAT0462 Secukinumab provides sustained pasdas related low disease activity in psoriatic arthritis: 2 year results from the future 2 study. Annals of the Rheumatic Diseases. 76. 948–949. 2 indexed citations
6.
7.
Smolen, Josef S, et al.. (2017). FRI0498 Outcomes associated with achievement of various treatment targets in patients with psoriatic arthritis receiving adalimumab. Annals of the Rheumatic Diseases. 76. 677–677. 6 indexed citations
8.
Perruccio, Anthony V., et al.. (2017). SAT0481 The relationship between the patient acceptable symptom state (PASS) and disease activity in patients with psoriatic arthritis (PSA). Annals of the Rheumatic Diseases. 76. 957–957. 2 indexed citations
9.
Eder, Lihi, DD Gladman, Dominique Ibañez, & Murray B. Urowitz. (2014). The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients. Lupus. 23(11). 1142–1148. 22 indexed citations
10.
Eder, Lihi, Murray B. Urowitz, & DD Gladman. (2013). Damage in lupus patients—what have we learned so far?. Lupus. 22(12). 1225–1231. 11 indexed citations
11.
Nikpour, Mandana, DD Gladman, & Murray B. Urowitz. (2013). Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand?. Lupus. 22(12). 1243–1250. 34 indexed citations
12.
Touma, Zahi, Murray B. Urowitz, Dominique Ibañez, & DD Gladman. (2011). SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation. Lupus. 20(1). 67–70. 65 indexed citations
13.
Nikpour, Mandana, Murray B. Urowitz, Dominique Ibañez, & DD Gladman. (2010). Relationship between cardiac symptoms, myocardial perfusion defects and coronary angiography findings in systemic lupus erythematosus. Lupus. 20(3). 299–304. 13 indexed citations
14.
Nikpour, Mandana, DD Gladman, Dominique Ibañez, & Murray B. Urowitz. (2009). Variability and correlates of high sensitivity C-reactive protein in systemic lupus erythematosus. Lupus. 18(11). 966–973. 16 indexed citations
15.
Hochman, Jacqueline, Murray B. Urowitz, Dominique Ibañez, & DD Gladman. (2009). Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease. Lupus. 18(4). 313–317. 20 indexed citations
16.
Touma, Zahi, Murray B. Urowitz, & DD Gladman. (2009). SLEDAI-2K for a 30-day window. Lupus. 19(1). 49–51. 64 indexed citations
17.
18.
Marra, Carlo A., Andreas Maetzel, Vernon T. Farewell, et al.. (2005). MS4 THE COST-EFFECTIVENESS OF ADDING INFLIXIMAB TO USUAL THERAPY IN THE TREATMENT OF PSORIATIC ARTHRITIS. Value in Health. 8(3). 242–242. 1 indexed citations
19.
Abu‐Shakra, Mahmoud, Murray B. Urowitz, DD Gladman, & Susan Ritchie. (1996). The significance of anticardiolipin antibodies in patients with lupus nephritis. Lupus. 5(1). 70–73. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Y Lian Breakdown of academic impact, for papers by Weng Giap Law Breakdown of academic impact, for papers by Michelle Petri Breakdown of academic impact, for papers by Ziqian Wang Breakdown of academic impact, for papers by K. Veres Breakdown of academic impact, for papers by Hector Arbillaga Breakdown of academic impact, for papers by Ka Lung Yu Breakdown of academic impact, for papers by Tina Mahajan Breakdown of academic impact, for papers by Shirley King Yee Ying Breakdown of academic impact, for papers by С. И. Глухова
Rankless by CCL
2026